Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s12265-020-09994-3.

Title:
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease | Journal of Cardiovascular Translational Research
Description:
Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory risk drives atherosclerotic cardiovascular disease in these patients. Additional anti-inflammatory therapeutic strategies are therefore required. The co-stimulatory molecule CD40 and its ligand CD40L (CD154) have a central role in the regulation of the inflammatory response during the development of atherosclerosis by modulating the interaction between immune cells and between immune cells and non-immune cells. In this review, we discuss the role of the CD40-CD40L dyad in atherosclerosis, and we discuss recent studies on the therapeutic potential of novel CD40-CD40L targeting strategies in cardiovascular medicine.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure if the website is profiting.

Not all websites are made for profit; some exist to inform or educate users. Or any other reason why people make websites. And this might be the case. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

pubmed, google, scholar, cas, cells, atherosclerosis, cardiovascular, inflammatory, cdl, interactions, atherosclerotic, central, coronary, patients, cell, journal, ligand, immune, disease, inflammation, cdcdl, activation, cdtraf, levels, scdl, risk, soluble, therapeutic, role, potential, research, acute, endothelial, cvd, inhibition, plaque, studies, protein, reduced, clinical, interaction, macrophages, vascular, expression, seijkens, elevated, heart, thrombosis, traf, article,

Topics {✒️}

nf-kappab/mir-125b axis monocyte/macrophage-driven inflammation high-sensitivity c-reactive protein restoring nf-kappab1 activation oxidized low-density lipoprotein beta3 integrin--dependent mechanism inhibit cd40-driven inflammation blocking cd40-traf6 signaling blocking cd40-traf6 interactions st-segment elevated mi elevated high-sensitive crp antibody anti-m7 blocks cd40 single-nucleotide polymorphisms circulating platelet-leukocyte aggregates anti-inflammatory agent colchicine small molecule-mediated inhibition deficient cd40-traf6 signaling maintaining protective host-defense evidence-based pharmaceutical targets sterile lps-induced sepsis genius-ii project ‘generating high-risk patient populations cd40l-cd40-traf6 axis thioglycolate-induced peritoneal macrophages anti-mac-1 hampered clearance molecular therapy--nucleic acids cd40-cd40 ligand signaling require long-term treatment van den berg develops atherosclerosis-related complications classical cd40l-mac1 interactions article download pdf tumour necrosis factor post-translational regulatory mechanisms cd40–cd40l–traf cascade chinese case-control study mediates leukocyte recruitment anti-cd40 sirna therapy c4bp-cd40 interactions occur promoting monocyte adhesion promising anti-inflammatory strategy cd40-cd40l targeting strategies heath-shock protein acute coronary syndrome-results immune checkpoint proteins cd40-traf2/3/5 interactions regulate cd40-traf2/3/5-mediated immunity platelet-leukocyte aggregates [3] long-term clinical outcomes single-nucleotide polymorphism

Questions {❓}

  • CD40 in coronary artery disease: a matter of macrophages?
  • HSP 70 and atherosclerosis--protector or activator?
  • Is there more than C-reactive protein and fibrinogen?
  • SCD40(L): A Biomarker for Atherosclerotic CVD?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
         description:Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory risk drives atherosclerotic cardiovascular disease in these patients. Additional anti-inflammatory therapeutic strategies are therefore required. The co-stimulatory molecule CD40 and its ligand CD40L (CD154) have a central role in the regulation of the inflammatory response during the development of atherosclerosis by modulating the interaction between immune cells and between immune cells and non-immune cells. In this review, we discuss the role of the CD40-CD40L dyad in atherosclerosis, and we discuss recent studies on the therapeutic potential of novel CD40-CD40L targeting strategies in cardiovascular medicine.
         datePublished:2020-03-28T00:00:00Z
         dateModified:2020-03-28T00:00:00Z
         pageStart:13
         pageEnd:22
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s12265-020-09994-3
         keywords:
            Cardiovascular disease
            Atherosclerosis
            Inflammation
            Immune checkpoint proteins
            CD40
            CD40L
            Cardiology
            Human Genetics
            Biomedical Engineering and Bioengineering
            Biomedicine
            general
            Medicine/Public Health
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12265-020-09994-3/MediaObjects/12265_2020_9994_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12265-020-09994-3/MediaObjects/12265_2020_9994_Fig2_HTML.png
         isPartOf:
            name:Journal of Cardiovascular Translational Research
            issn:
               1937-5395
               1937-5387
            volumeNumber:14
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Laura A. Bosmans
               affiliation:
                     name:University of Amsterdam
                     address:
                        name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lena Bosch
               affiliation:
                     name:University Medical Center Utrecht
                     address:
                        name:Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pascal J.H. Kusters
               affiliation:
                     name:University of Amsterdam
                     address:
                        name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:University of Amsterdam
                     address:
                        name:Department of Pathology, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Esther Lutgens
               affiliation:
                     name:University of Amsterdam
                     address:
                        name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
                     name:Ludwig Maximilian’s University
                     address:
                        name:Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian’s University, Munich, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance
                     address:
                        name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Tom T.P. Seijkens
               affiliation:
                     name:University of Amsterdam
                     address:
                        name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
      description:Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory risk drives atherosclerotic cardiovascular disease in these patients. Additional anti-inflammatory therapeutic strategies are therefore required. The co-stimulatory molecule CD40 and its ligand CD40L (CD154) have a central role in the regulation of the inflammatory response during the development of atherosclerosis by modulating the interaction between immune cells and between immune cells and non-immune cells. In this review, we discuss the role of the CD40-CD40L dyad in atherosclerosis, and we discuss recent studies on the therapeutic potential of novel CD40-CD40L targeting strategies in cardiovascular medicine.
      datePublished:2020-03-28T00:00:00Z
      dateModified:2020-03-28T00:00:00Z
      pageStart:13
      pageEnd:22
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s12265-020-09994-3
      keywords:
         Cardiovascular disease
         Atherosclerosis
         Inflammation
         Immune checkpoint proteins
         CD40
         CD40L
         Cardiology
         Human Genetics
         Biomedical Engineering and Bioengineering
         Biomedicine
         general
         Medicine/Public Health
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12265-020-09994-3/MediaObjects/12265_2020_9994_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs12265-020-09994-3/MediaObjects/12265_2020_9994_Fig2_HTML.png
      isPartOf:
         name:Journal of Cardiovascular Translational Research
         issn:
            1937-5395
            1937-5387
         volumeNumber:14
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Laura A. Bosmans
            affiliation:
                  name:University of Amsterdam
                  address:
                     name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lena Bosch
            affiliation:
                  name:University Medical Center Utrecht
                  address:
                     name:Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pascal J.H. Kusters
            affiliation:
                  name:University of Amsterdam
                  address:
                     name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:University of Amsterdam
                  address:
                     name:Department of Pathology, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Esther Lutgens
            affiliation:
                  name:University of Amsterdam
                  address:
                     name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
                  name:Ludwig Maximilian’s University
                  address:
                     name:Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian’s University, Munich, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance
                  address:
                     name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Tom T.P. Seijkens
            affiliation:
                  name:University of Amsterdam
                  address:
                     name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Cardiovascular Translational Research
      issn:
         1937-5395
         1937-5387
      volumeNumber:14
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Amsterdam
      address:
         name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:University Medical Center Utrecht
      address:
         name:Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
         type:PostalAddress
      name:University of Amsterdam
      address:
         name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:University of Amsterdam
      address:
         name:Department of Pathology, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:University of Amsterdam
      address:
         name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
      name:Ludwig Maximilian’s University
      address:
         name:Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian’s University, Munich, Germany
         type:PostalAddress
      name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance
      address:
         name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
         type:PostalAddress
      name:University of Amsterdam
      address:
         name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Laura A. Bosmans
      affiliation:
            name:University of Amsterdam
            address:
               name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Lena Bosch
      affiliation:
            name:University Medical Center Utrecht
            address:
               name:Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
               type:PostalAddress
            type:Organization
      name:Pascal J.H. Kusters
      affiliation:
            name:University of Amsterdam
            address:
               name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
            name:University of Amsterdam
            address:
               name:Department of Pathology, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      name:Esther Lutgens
      affiliation:
            name:University of Amsterdam
            address:
               name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
            name:Ludwig Maximilian’s University
            address:
               name:Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian’s University, Munich, Germany
               type:PostalAddress
            type:Organization
            name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance
            address:
               name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
               type:PostalAddress
            type:Organization
      name:Tom T.P. Seijkens
      affiliation:
            name:University of Amsterdam
            address:
               name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
      name:Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands
      name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
      name:Department of Pathology, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
      name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands
      name:Institute for Cardiovascular Prevention (IPEK), Ludwig Maximilian’s University, Munich, Germany
      name:German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany
      name:Department of Medical Biochemistry, Amsterdam Cardiovascular Sciences (ACS), Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands

External Links {🔗}(202)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.67s.